Friday, January 18, 2013 2:13:01 AM
Company Overview
Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid P...Detailed Description
1127 41st Avenue East
Seattle, WA 98112
United States
Founded in 2000
26 Employees
Phone:
206-325-2412
www.protivabio.com
Key Executives for Protiva Biotherapeutics, Inc.
Dr. Mark J. Murray
Chief Executive Officer
Mr. Martin C. McConnell
Chief Financial Officer
Dr. Ian MacLachlan
Chief Scientific Officer and Executive Vice President
Dr. Peter Lutwyche
Vice President of Pharmaceutical Development
Compensation as of Fiscal Year 2012.
Tekmira Pharmaceutical
TEKMIRA PHARMACEUTICALS CORPORATION
(Exact name of Registrant as specified in its charter)
British Columbia 2834 980597776
(Province or other Jurisdiction of
Incorporation or Organization) (Primary Standard Industrial
Classification Code Number) (I.R.S. Employer
Identification Number, if any)
100-8900 Glenlyon Parkway
Burnaby, British Columbia
Canada, V5J 5J8
(604) 419-3200
(Address and telephone number of Registrant’s principal executive offices)
National Registered Agents, Inc.
1780 Barnes Blvd. S.W. Bldg. G
Tumwater, Washington 98512-0410
(206) 381-8840
(Name, address (including zip code) and telephone number (including area code) of agent for service in the United States)
Copies to:
Daniel M. Miller
Dorsey & Whitney LLP
Suite 1605, 777 Dunsmuir Street
Pacific Centre
Vancouver, British Columbia
Canada V7Y 1K4
Mark J. Murray
Ian C. Mortimer
Tekmira Pharmaceuticals Corporation
100-8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8
(604) 419-3212
_________________________________________________________
Two companies?
Echo20
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM